Home / BusinessBusinessCNBCBusinessCNBC·Sep 8, 2026·1 min read'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threatSandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.View original source — CNBC ↗ShareCopy linkShare on XShare on FacebookRelated storiesBusinessBloombergBusinessSep 3, 2026 · 1 minTrump to Levy More Chip Tariffs to Boost ManufacturingBloombergTechnologyThe Next WebTechnologySep 4, 2026 · 1 minWacker weighs closing Tennessee polysilicon plant after Trump tariffs, Reuters reportsThe Next WebBusinessFrance 24BusinessJun 19, 2026 · 1 minUS launches Germany pharma pricing probe, raising threat of new tariffsFrance 24HealthAllAfricaHealthSep 2, 2026 · 1 minKenya: Pharmaceutical Manufacturers Warn of Disruptions Over Delayed Vat ExemptionsAllAfrica
BusinessBloombergBusinessSep 3, 2026 · 1 minTrump to Levy More Chip Tariffs to Boost ManufacturingBloomberg
TechnologyThe Next WebTechnologySep 4, 2026 · 1 minWacker weighs closing Tennessee polysilicon plant after Trump tariffs, Reuters reportsThe Next Web
BusinessFrance 24BusinessJun 19, 2026 · 1 minUS launches Germany pharma pricing probe, raising threat of new tariffsFrance 24
HealthAllAfricaHealthSep 2, 2026 · 1 minKenya: Pharmaceutical Manufacturers Warn of Disruptions Over Delayed Vat ExemptionsAllAfrica